Isomorphic Labs' chief executive, Sir Demis Hassabis, delivering his Nobel Prize lecture in 2024. Alphabet-backed start-up Isomorphic Labs has added to the lustre attached to its AI-powered drug ...
All the Latest Game Footage and Images from Our Red String Lena and Ian are two very different people who find themselves in a very similar moment in their lives. Both struggling to achieve their ...
After breaking his leg in a backstage skateboarding accident in April, Billy Strings returned to the stage Sunday night (May 31) at Les Claypool’s concert in Detroit. The celebrated bluegrass musician ...
The race to use artificial intelligence for designing medicines is rapidly becoming one of the most expensive and closely watched bets in technology and biotech. On 12 May 2026, Isomorphic Labs ...
If you could take an apple and break it into smaller and smaller parts, you would find molecules, then atoms, followed by subatomic particles like protons and the quarks and gluons that make them up.
Isomorphic Labs, an AI drug discovery and development company, raised $2.1 billion in a Series B funding round led by Thrive Capital. The raise was also backed by existing investors Alphabet and GV ...
Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it might bring to the clinic. “We’re aiming to redefine the way we create new ...
The organisation plans to use the investment as a means of accelerating the application of its AI model at scale. AI-powered drug design and development company Isomorphic Labs has announced a raise ...
Isomorphic Labs, the AI-first drug discovery company founded by Demis Hassabis, has raised $2.1 billion in a Series B funding round as competition intensifies around artificial intelligence-driven ...
May 12 (Reuters) - Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion in its latest funding round led by existing investor Thrive ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...